Fantofarone
CAS No. 114432-13-2
Fantofarone( SR 33557 | SR-33557 | Fantofarone )
Catalog No. M17837 CAS No. 114432-13-2
Fantofarone is a highly potent Calcium Channel antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 222 | In Stock |
|
| 50MG | 368 | In Stock |
|
| 100MG | 478 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFantofarone
-
NoteResearch use only, not for human use.
-
Brief DescriptionFantofarone is a highly potent Calcium Channel antagonist.
-
DescriptionFantofarone, also known as SR 33557, is a highly potent calcium channel antagonist representative of a new class of slow channel blockers. Fantofarone can significantly modify cardiac function and in particular, decrease MO2C consumption during periods of elevated heart rate. Fantofarone is able to induce submaximal peripheral vasodilating effects at doses that are devoid of any clinically significant cardiac effect.
-
In VitroIt can be seen that the calcium channel blockers VIZ and Fantofarone (SR) possess a weak intrinsic antimalarial property compared to CQ, and both appear slightly more potent on the CQ-resistant than on the CQ-sensitive parasites. Interestingly, Fantofarone is ca. 10 times more potent than verapamil. Fantofarone (SR) is 10 times more potent than the phenylalkylamine verapamil (VR) on the two P. fdciparum strains. As revealed by the isobolograms, the two calcium channel blockers potentiate the CQ sensitivity activity on the CQ-resistant P. fufcipurum strain, verapamil appearing 2 to 3 times more potent than Fantofarone. Furthermore, when used at similar subinhibitory fractions of their IC50, VR is 2 to 3 times more potent than Fantofarone in decreasing CQ resistance.
-
In VivoTreatment with isosorbide dinitrate (0.3 mg/kg, i.v.) or Fantofarone (50 mg/kg, i.v.), a reduction is observed in the occurrence and severity of vasospasm, whereas verapamil (0.2 mg/kg, i.v.) is much less effective. Although it totally inhibits distal AIV, isosorbide dinitrate does not significantly affect proximal diameter decrease. The most potent compound with regard to both the distal and proximal vasospasms is Fantofarone, which significantly reduces AIV throughout the experiment. Verapamil does not reduce AIV significantly.
-
SynonymsSR 33557 | SR-33557 | Fantofarone
-
PathwayOthers
-
TargetOther Targets
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114432-13-2
-
Formula Weight550.72
-
Molecular FormulaC31H38N2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 150 mg/mL 272.38 mM;
-
SMILESCOc1ccc(cc1OC)CCN(C)CCCOc2ccc(cc2)S(=O)(=O)c3c4ccccn4cc3C(C)C
-
Chemical NameN-(3,4-dimethoxyphenethyl)-3-(4-((2-isopropylindolizin-1-yl)sulfonyl)phenoxy)-N-methylpropan-1-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Adovelande J, et al. Biochem Pharmacol. 1998 Feb 15;55(4):433-40.
molnova catalog
related products
-
RIG012
RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM (measured by NADH-coupled ATPase), and it inhibits the expression of IFN-β and ISG hRsad2.
-
SI 60
Sanaid SI 60 is an aromatic sulfonium salt and is initiator for thermosetting polymerization at low temperature.
-
GDC-0623
GDC-0623 is a potent and ATP-uncompetitive MEK1 inhibitor with Ki of 0.13 nM. Phase 1.
Cart
sales@molnova.com